Several studies presented at the 2015 ESMO World Congress on Gastrointestinal Cancer offered new promise for patients.
August 2015
The unprecedented, soaring price of anticancer drugs (and cancer care) is not sustainable and has truly not been addressed.
A new test reveals which patients with leukemia and other blood disorders are likely to respond to treatment for graft-versus-host disease that develops after a stem cell transplant.
Palliative care should address the unique symptom profile of gynecologic cancer and be tailored to individual socioeconomic environments.
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5